Moscatilin from the Orchid Dendrobrium loddigesii Is a Potential Anticancer Agent

Cancer Investigation

Volumn 21, Issue 5, 2003, Pages 729-736

  Ho, Chi Kuan ^a   Chen, Chieh Chih ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Anticancer drug; Chemotherapy; Moscatilin

Indexed keywords

CYCLIN B; CYCLIN DEPENDENT KINASE; DENDROBIUM LODDIGESII EXTRACT; MOSCATILIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY FLUID; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE G2 PHASE; CHEMOPROPHYLAXIS; CHINESE MEDICINE; CYTOTOXICITY; DENDROBIUM LODDIGESII; DRUG ISOLATION; DRUG STRUCTURE; FEVER; HUMAN; HUMAN CELL; LIVER; LUNG; PLACENTA; PLANT; PRIORITY JOURNAL; STOMACH;

BENZYL COMPOUNDS; CHEMOPREVENTION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; G2 PHASE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; ORCHIDACEAE; PLACENTA; PLANT EXTRACTS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0242665397     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120023771     Document Type: Article

References (20)

1. Majumder, P.L.; Sen, R.C. Moscatilin, a bibenzyl derivative from the orchid dendrobrium moscatum. Phytochemistry 1987, 26, 2121-2125.
2. Hsu, H.Y.; Chen, Y.P.; Sheu, S.J.; Hsu, C.S.; Chen, C.C.; Chang, H.C. Oriental Materia Medica - a Concise Guide; Oriental Healing Arts Institute: Los Angeles, 1986; p. 582.
3. Chen, C.C.; Wu, L.G.; Ko, F.N.; Teng, C.M. Antiplatelet aggregation principles of Dendrobrium loddigesii. J. Nat. Prod. 1994, 57, 1271-1274.
4. King, R.W.; Jackson, P.K.; Kirschner, M.W. Mitosis in transition. Cell 1994, 79, 563-571.
5. Togoshima, F.; Moriguchi, T.; Wada, A.; Fukuda, M.; Nishida, E. Nuclear export of cyclin B1 and its possible roles in the DNA damages-induced G2 checkpoint. EMBO J. 1998, 17, 2728-2735.
6. Atherton, F.S.; Packen, L.L.; Geahlen, R.L.; Piwnica-Worms, H. Mechanisms of p34 cdc 2 regulation. Mol. Cell. Biol. 1993, 13, 1585-1675.
7. Ho, C.K.; Wang, C.C.; Li, S.Y.; Chiang, H.; Yu, K.J.; Wang, S.Y. Characterization of a human tumorigenic poorly differentiated trophoblast cell line. In Vitro 1994, 30A, 415-417.
8. Lin, J.H.; Tong, M.J.; Stevenson, D. A new human hepatocellular carcinoma cell line secreting hepatitis B surface antigen and alpha-fetoprotein (abstr). In Viral Hepatitis and Liver Disease; Vyas, G.N., Dienstag, J.L., Hoofragle, J.H., Eds.; Orlando, Grune & Atralton 671, 1984.
9. Chang, C.; Lin, Y.; O-Lee, T.W.; Chou, C.K.; Lee, T.S.; Liu, T.J.; P'eng, F.K.; Chen, T.Y.; Hu, C.P. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol. Cell. Biol. 1983, 2, 1133.
10. Taki, T.; Ishikawa, H.; Imai, K.; Yachi, A.; Matsumoto, M. Immunological analysis of glycolipids on cell surfaces of cultured human tumor cell lines: expression of lactoneotetrasylcaramide on tumor cell surfaces. J. Biochem. 1985, 98, 887-895.
11. Baba, M.; Hasegawa, H.; Nakayaba, M.; Shimiza, N.; Suzuki, S.; Kamada, N.; Tani, K. Establishment and characterization of a gastric cancer cell line (HUGC-00HIRA) producing high levels of G-CSF, GM-CSF and IL-6: the presence of autocrine growth control by G-CSF. Am. J. Hematol. 1995, 49, 207-215.
12. Mosmann, T. A rapid colorimetric assay for cellular growth and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
13. Ongkeko, W.; Ferguson, D.J.P.; Harris, A.L.; Norbury, C. Inactivation of cdc 2 increases the level of apoptosis induced by DNA damage. J. Cell Sci. 1995, 108, 2897-2904.
14. cdc2/cylin B. Cancer Res. 1992, 52, 1823-1829.
15. cdc2 tyrosine dephosphorylation and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res. 1992, 52, 1817-1822.
16. Meijer, L.; Borgne, A.; Mulner, O.; Chong, J.P.J.; Blow, J.L.; Inagaki, N.; Inagaki, M.; Deleros, J.; Moulinoux, J. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc 2, cdk 2 and cdk 5. Eur. J. Biochem. 1997, 243, 527-536.
17. cdc 2 kinase in vitro and in extracts from human H69 cells. Evidence for a double mechanism of action. Biochem. Biophys. Res. Commun. 1994, 203, 1574-1580.
18. cda 2-like kinases. Biochem. Biophys. Res. Commun. 1992, 184, 80-85.
19. Losiewicz, M.D.; Carlson, B.A.; Kaur, G.; Sausville, E.A.; Worland, P.J. Potent inhibition of cdc 2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun. 1994, 201, 589-595.
20. Estamen, A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990, 2, 275-280.